Invention Grant
- Patent Title: Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
-
Application No.: US12665350Application Date: 2008-06-24
-
Publication No.: US09610340B2Publication Date: 2017-04-04
- Inventor: Ralph Leon Biemans , Nathalie Marie-Josephe Garçon , Philippe Vincent Hermand , Jan Poolman , Marcelle Paulette Van Mechelen
- Applicant: Ralph Leon Biemans , Nathalie Marie-Josephe Garçon , Philippe Vincent Hermand , Jan Poolman , Marcelle Paulette Van Mechelen
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee Address: BE Rixensart
- Agent Barbara J. Carter
- Priority: GB0712420.9 20070626; GB0712428.2 20070626; GB0712435.7 20070626
- International Application: PCT/EP2008/057999 WO 20080624
- International Announcement: WO2009/000826 WO 20081231
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K47/48 ; A61K39/00 ; A61K39/116
Abstract:
The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various conjugated capsular saccharides from different S. pneumoniae serotypes conjugated to 2 or more different carrier proteins, where the composition comprises serotype 19F capsular saccharide conjugated to diphtheria toxoid (DT) or CRM197, optionally wherein 19F is the only saccharide in the composition conjugated to diphtheria toxoid (DT) or CRM197.
Public/Granted literature
- US20100209450A1 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES Public/Granted day:2010-08-19
Information query
